Device programming of the rechargeable InterStim Micro sacral neuromodulation device through 12 months in a global post-market study

Authors

Marie-Aimee Perrouin-Verbe, Centre Hospitalier Universitaire de Nantes, France
Colin Goudelocke, Ochsner Medical Center, New Orleans, LA
Keith Xavier, Urology Partners of North Texas, Arlington, TX
Barry Pecha, First Urology, Jeffersonville, IN
Kimberly Burgess, Prisma Health, Greenville
Ryan Krlin, LSU Health Sciences Center - New OrleansFollow
Jodi Michaels, Center for Continence Care, Minnesota Urology
Sagar Shah, East Coast Institute for Research LLC, Jacksonville, FL
Benoit Peyronnet, Centre Hospitalier Universitaire de Rennes, France
Stanley Zaslau, West Virginia University, Morgantown, WV
Bianca Papi, Medtronic, Minneapolis, MN
D. U. J. Keller, Medtronic, Tolochenaz, Switzerland
Dean Elterman, University of Toronto, Canada
Victor Nitti, University of California Los Angeles

Document Type

Conference Proceeding

Publication Date

2-10-2023

Publication Title

European Urology

Abstract

EAU23 - 38th Annual EAU Congress, March 10 - 13, 2023, Milan, Italy

First Page

S989

Last Page

S990

Volume

83

Issue

Supplement 1

Recommended Citation

Perrouin-Verbe, Marie-Aimee; Goudelocke, Colin; Xavier, Keith; Pecha, Barry; Burgess, Kimberly; Krlin, Ryan; Michaels, Jodi; Shah, Sagar; Peyronnet, Benoit; Zaslau, Stanley; Papi, Bianca; Keller, D. U. J.; Elterman, Dean; and Nitti, Victor, "Device programming of the rechargeable InterStim Micro sacral neuromodulation device through 12 months in a global post-market study" (2023). School of Medicine Faculty Publications. 2383.
https://digitalscholar.lsuhsc.edu/som_facpubs/2383
10.1016/S0302-2838(23)00747-9